Determining the Role of the Gut Microbiome in Melanoma Treated With Anti–PD-1 ICIs
Patients who responded to anti–PD-1 therapy and experienced prolonged progression-free survival had a much greater diversity of gut bacteria.
Role of Gut Microbiome in Metastatic Melanoma Patients on Immunotherapy
In this interview we discuss the effect of the gut microbiome on responses and survival outcomes in metastatic melanoma patients treated with anti–PD-1 immunotherapies.
2 Commerce Drive Cranbury, NJ 08512